Summary of Study ST002817

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001748. The data can be accessed directly via it's Project DOI: 10.21228/M8RQ7M This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Perform statistical analysis  |  Show all samples  |  Show named metabolites  |  Download named metabolite data  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002817
Study TitleInvestigation of metabolism in hypertrophic cardiomyopathy - Lipidomics
Study SummaryWe propose the use of targeted metabolomics to define the metabolic and molecular pathways altered in 2 mouse models (R92W-TnT and R403Q-MHC) of hypertrophic cardiomyopathy (HCM) that span the spectrum of human disease (heart failure and sudden death), with the goal of identifying treatment targets. Parallel targeted metabolomics studies will be performed in heart tissue and plasma at rest and following inotrope stimulation. Since energy compromise is expected to be most marked when the heart is subject to increased workload, as is the case during high-intensity exercise or inotropic stimulation, we propose metabolomics studies in heart tissue and plasma, at rest and following inotrope stimulation. We anticipate that the results of these studies will allow us to move forward with further investigations into specific metabolites of interest as biomarkers, to be tested in HCM patients in future studies.
Institute
University of California, San Francisco
DepartmentHypertrophic Cardiomyopathy Center of Excellence
LaboratoryUCSF Smith Cardiovascular Research Building
Last NameAbraham
First NameMaria Roselle
Address555 Mission Bay Boulevard South, San Francisco, CA 94158
EmailRoselle.Abraham@ucsf.edu
Phone415-502-3911
Submit Date2023-07-27
Num Groups2 groups of 2 (i.e., mutant vs control of two mouse models of HCM (R402Q-MyHC, R92W-TnT)
Total Subjects32
Raw Data AvailableYes
Raw Data File Type(s)d
Analysis Type DetailLC-MS
Release Date2023-09-06
Release Version1
Maria Roselle Abraham Maria Roselle Abraham
https://dx.doi.org/10.21228/M8RQ7M
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Combined analysis:

Analysis ID AN004584 AN004585 AN004586
Analysis type MS MS MS
Chromatography type Reversed phase Reversed phase Reversed phase
Chromatography system Agilent 1290 Agilent 1290 Waters Acquity
Column Waters ACQUITY UPLC CSH C18 (100 x 1mm,1.7um) Waters ACQUITY UPLC CSH C18 (100 x 1mm,1.7um) Waters ACQUITY UPLC BEH C18 (100 x 2.1mm,1.7um)
MS Type ESI ESI ESI
MS instrument type QTOF QTOF Orbitrap
MS instrument name Agilent 6530 QTOF Agilent 6550 QTOF Thermo Q Exactive Orbitrap
Ion Mode POSITIVE NEGATIVE POSITIVE
Units peak heights peak heights raw area counts rescaled to set the median equal to 1
  logo